Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Ccx140-b
1. 1100318-47-5
2. Ccx140
3. Ilacirnon
4. Ccx140-b
5. Ilacirnon [usan]
6. Ccx-140
7. Chembl2178573
8. 380f68j5ph
9. Mfcd30378911
10. 4-chloro-n-[5-methyl-2-(7h-pyrrolo[2,3-d]pyrimidine-4-carbonyl)pyridin-3-yl]-3-(trifluoromethyl)benzenesulfonamide
11. 4-chloro-n-(5-methyl-2-(7h-pyrrolo(2,3-d)pyrimidin-4-ylcarbonyl)-3-pyridinyl)-3-(trifluoromethyl)benzenesulfonamide
12. 4-chloro-n-(5-methyl-2-(7h-pyrrolo[2,3-d]pyrimidine-4-carbonyl)pyridin-3-yl)-3-(trifluoromethyl)benzenesulfonamide
13. Ilacirnon [inn]
14. Ccx140b
15. Schembl127113
16. Unii-380f68j5ph
17. Ccx-140b
18. Ccx140-bccx140-b
19. Gtpl11185
20. Ccx140b; Ccx140 B
21. Bcp25695
22. Ex-a2956
23. Ac1940
24. Bdbm50398343
25. Who 11339
26. Zinc43204193
27. Cs-6448
28. Example 5 [wo2009009740a1]
29. Ac-31374
30. Cs-12273
31. Sy044972
32. Db-106774
33. Hy-101713
34. 4-chloro-n-(5-methyl-2-(7h-pyrrolo[2,3-d]pyrimidine-4-carbonyl)pyridin-3-yl)-3-(trifluoromethyl)benzenesulfonamidedine-4-carbonyl)pyridin-3-yl)-3-(trifluoromethyl)benzenesulfonamide
35. 4-chloro-n-[5-methyl-2-(7h-pyrrolo[2,3-d]pyrimidine-4-carbonyl)-pyridin-3-yl]-3-trifluoromethyl-benzenesulfonamide
36. Benzenesulfonamide, 4-chloro-n-(5-methyl-2-(7h-pyrrolo(2,3-d)pyrimidin-4-ylcarbonyl)-3-pyridinyl)-3-(trifluoromethyl)-
| Molecular Weight | 495.9 g/mol |
|---|---|
| Molecular Formula | C20H13ClF3N5O3S |
| XLogP3 | 4.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 5 |
| Exact Mass | 495.0379726 g/mol |
| Monoisotopic Mass | 495.0379726 g/mol |
| Topological Polar Surface Area | 126 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 827 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
67
PharmaCompass offers a list of CCX140 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right CCX140 manufacturer or CCX140 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred CCX140 manufacturer or CCX140 supplier.
PharmaCompass also assists you with knowing the CCX140 API Price utilized in the formulation of products. CCX140 API Price is not always fixed or binding as the CCX140 Price is obtained through a variety of data sources. The CCX140 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CCX140 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CCX140, including repackagers and relabelers. The FDA regulates CCX140 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CCX140 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A CCX140 supplier is an individual or a company that provides CCX140 active pharmaceutical ingredient (API) or CCX140 finished formulations upon request. The CCX140 suppliers may include CCX140 API manufacturers, exporters, distributors and traders.
CCX140 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CCX140 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CCX140 GMP manufacturer or CCX140 GMP API supplier for your needs.
A CCX140 CoA (Certificate of Analysis) is a formal document that attests to CCX140's compliance with CCX140 specifications and serves as a tool for batch-level quality control.
CCX140 CoA mostly includes findings from lab analyses of a specific batch. For each CCX140 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CCX140 may be tested according to a variety of international standards, such as European Pharmacopoeia (CCX140 EP), CCX140 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CCX140 USP).
